Competitive neuronal nicotinic receptor antagonists: A new direction for drug discovery

Linda P. Dwoskin, Peter A. Crooks

Research output: Contribution to journalReview articlepeer-review

121 Scopus citations

Abstract

Neuronal nicotinic acetylcholine receptors are distributed extensively throughout the central and peripheral nervous systems. Currently, there is great interest in determining the structural and functional diversity of these receptors and in developing subtype-selective agonists that have potential as therapeutic agents for neuropathology and disease. However, relatively little attention has been focused on the development of subtype-selective nicotinic receptor antagonists. Such antagonists would be beneficial for establishing the role of specific nicotinic receptor subtypes in physiological function and for unraveling the complexities of neuronal nicotinic receptor function. Furthermore, these subtype-selective antagonists may also prove to be beneficial in the treatment of neuropathology and disease. The current perspective summarizes the research that has been carried out with both classical competitive antagonists and more recently developed competitive nicotinic receptor antagonists.

Original languageEnglish
Pages (from-to)395-402
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume298
Issue number2
StatePublished - 2001

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Fingerprint

Dive into the research topics of 'Competitive neuronal nicotinic receptor antagonists: A new direction for drug discovery'. Together they form a unique fingerprint.

Cite this